Presentation Information
[Pe-028-2]Characteristics of double-positivity for AQP4- and MOG-IgG in Japan
Naoya Yamazaki1, Tatsuro Misu1, Mizuki Otomo1, Naohiro Sakamoto1, Naoki Yamamoto1, Shu Umezawa1, Chihiro Namatame1, Hirohiko Ono1, Kimihiko Kaneko1, Yoshiki Takai1, Shuhei Nishiyama1, Hiroshi Kuroda3,4, Toshiyuki Takahashi2, Kazuo Fujihara3,4, Masashi Aoki1 (1.Department of Neurology, Tohoku University Hospital, Japan, 2.Department of Neurology, National Hospital Organization Yonezawa National Hospital, Japan, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 4.Department of Multiple Sclerosis Therapeutics and Southern Tohoku Research Institute for Neuroscience, Multiple Sclerosis, Japan)